Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings, Inc. (AMBS) Stock Ownership
Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).
SEC 13F · FMP · AMBS · as of —
Ownership Breakdown
Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.
No institutional data available for this period.
Insider Buying vs Selling
AMBS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
COMMISSIONG GERALD CEO | Feb 1, 2016 | J-Other | 45,283 | $0.27 | $12.0K | 100.3K | Form 4 ↗ |
FARRELL ROBERT EDWARD CFO | Apr 9, 2015 | Purchase | 200,000 | $0.05 | $10.0K | 333.3K | Form 4 ↗ |
COMMISSIONG GERALD CEO | Apr 8, 2015 | Purchase | 203,000 | $0.05 | $9.7K | 8.26M | Form 4 ↗ |
COMMISSIONG GERALD CEO | Apr 8, 2015 | Purchase | 37,000 | $0.05 | $1.8K | 8.06M | Form 4 ↗ |
Huffman Donald D director | Jan 12, 2015 | Award | 6,490,000 | $0.08 | $519.2K | 6.49M | Form 4 ↗ |
FARRELL ROBERT EDWARD CFO | Nov 19, 2014 | Purchase | 133,333 | $0.07 | $10.0K | 133.3K | Form 4 ↗ |
COMMISSIONG GERALD CEO | Nov 20, 2014 | Purchase | 10,000 | $0.08 | $768 | 8.02M | Form 4 ↗ |
COMMISSIONG GERALD CEO | Nov 20, 2014 | Purchase | 36,000 | $0.07 | $2.7K | 8.01M | Form 4 ↗ |
COMMISSIONG GERALD CEO | Nov 20, 2014 | Purchase | 84,000 | $0.08 | $6.5K | 7.97M | Form 4 ↗ |
COMMISSIONG GERALD CEO | Sep 22, 2014 | Award | 5,000,000 | $0.09 | $438.0K | 5.00M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Amarantus BioScience Holdings, Inc. (AMBS) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.
A total of 0 institutional investors currently hold AMBS stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
AMBS ownershipAmarantus BioScience Holdings, Inc. (AMBS) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.